| HealthPartners | Oncology - trastuzumab (Herceptin®, Herzuma®, | 2025-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2025-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2025-07-01 |
| HealthPartners | Pegloticase (Krystexxa®) | 2025-07-01 |
| HealthPartners | Pegloticase (Krystexxa®) - Minnesota Health Care | 2025-07-01 |
| HealthPartners | Recent Food and Drug Administration (FDA) approved | 2025-07-01 |
| HealthPartners | Romosozumab-aqqg (Evenity®) | 2025-07-01 |
| HealthPartners | Romosozumab-aqqg (Evenity®) – Minnesota Health | 2025-07-01 |
| HealthPartners | Somatostatin analogues for acromegaly (Sandostatin | 2025-07-01 |
| HealthPartners | Third party payments | 2025-07-01 |